Avacta Group Plc (LON:AVCT – Get Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 57.99 ($0.73) and traded as low as GBX 48 ($0.60). Avacta Group shares last traded at GBX 48.70 ($0.61), with a volume of 516,713 shares changing hands.
Avacta Group Trading Down 1.6 %
The company has a debt-to-equity ratio of 63.54, a current ratio of 1.29 and a quick ratio of 4.96. The company has a market capitalization of £174.49 million, a price-to-earnings ratio of -541.11 and a beta of 1.12. The business’s 50-day moving average price is GBX 49.30 and its two-hundred day moving average price is GBX 57.99.
Avacta Group Company Profile
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
Featured Stories
- Five stocks we like better than Avacta Group
- Low PE Growth Stocks: Unlocking Investment Opportunities
- S&P 500 ETFs: Expense Ratios That Can Boost Your Long-Term Gains
- Expert Stock Trading Psychology Tips
- How AI Implementation Could Help MongoDB Roar Back in 2025
- The Significance of Brokerage Rankings in Stock Selection
- Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
